ISSN: 2226-3624
Open access
This paper develops a stakeholder-theory perspective on sustainable governance of pharmacy supply chains with artificial intelligence (AI) integration. It situates the problem in global, ASEAN, and Malaysian contexts where risks from substandard and falsified products, medication-safety losses, and uneven regulatory capacity challenge supply-chain integrity. Stakeholder theory is used to frame how regulators, manufacturers, distributors, pharmacists, patients, payers, and technology providers shape incentives for data sharing, transparency, safety, and environmental performance. Evidence from international guidance and regional policy shows how Good Distribution Practice, data-protection laws, and ASEAN pharmaceutical harmonization can be operationalised together with AI tools for forecasting, traceability, inventory stewardship, and cold-chain assurance. A conceptual governance model is proposed that links AI functionalities to stakeholder expectations and measurable outcomes, including safety incidents, stock-out frequency, waste reduction, and patient trust. The paper outlines researchable propositions and a mixed-methods agenda for empirical validation in Malaysia and across ASEAN, where rapid digital adoption and evolving health-data regulation create both opportunities and risks.
Adekola, A. D., Kassem, R. G., & Mbata, A. O. (2022). Convergence of AI, blockchain, and pharmacoeconomics in building adaptive pharmaceutical supply chains: A novel paradigm shift for equitable global drug access. Int J Sci Res Updates, 4(1), 356-74.
Al-Hourani, S., & Weraikat, D. (2025). A Systematic Review of Artificial Intelligence (AI) and Machine Learning (ML) in Pharmaceutical Supply Chain (PSC) Resilience: Current Trends and Future Directions. Sustainability, 17(14), 6591.
Al-Hourani, S., Mudabber, A., & Ahmed, A. (2025). A systematic review of artificial intelligence and sustainable supply chains: Evidence, gaps and future agenda. Sustainability, 17(14), 6591
ASEAN Secretariat. (2016). ASEAN Common Technical Dossier (ACTD): Table of contents and organization.
ASEAN Secretariat. (2021). ASEAN Common Technical Requirements (ACTR).
ASEAN-Japan Centre. (2024). Assessing digital health adoption in ASEAN.
Bade, C., Olsacher, A., Boehme, P., Truebel, H., Bürger, L., & Fehring, L. (2024). Sustainability in the pharmaceutical industry—An assessment of sustainability maturity and effects of sustainability measure implementation on supply chain security. Corporate Social Responsibility and Environmental Management, 31(1), 224-242.
Bukhari, N., Dawoud, D., & Mariam, A. (2021). Geospatial analysis of distribution of community pharmacies and characteristics of the populations they serve: A case study of Malaysia. Journal of Pharmaceutical Policy and Practice, 14(74).
Damoah, I. S., Ayakwah, A., & Tingbani, I. (2021). Artificial intelligence (AI)-enhanced medical drones in the healthcare supply chain (HSC) for sustainability development: A case study. Journal of Cleaner Production, 328, 129598.
Debnath, B., Shakur, M. S., Bari, A. M., Saha, J., Porna, W. A., Mishu, M. J., ... & Rahman, M. A. (2023). Assessing the critical success factors for implementing industry 4.0 in the pharmaceutical industry: implications for supply chain sustainability in emerging economies. Plos one, 18(6), e0287149.
Department of Personal Data Protection Malaysia. (2013). Personal Data Protection Act 2010 (Act 709). Government of Malaysia.
Donkor, F., Papadopoulos, T., & Spiegler, V. (2024). Supply chain integration and supply chain sustainability relationship: A qualitative analysis of the UK and Ghana pharmaceutical industry. Production Planning & Control, 35(6), 535-558.
Freeman, R. E. (1984). Strategic management: A stakeholder approach. Pitman.
Ghadge, A., Tsanis, K., Tiwari, A., Kumar, M., & Chakraborty, A. (2023). Blockchain implementation in pharmaceutical supply chains: A review and conceptual framework. International Journal of Production Research, 61(24), 8451–8476.
GSMA. (2023). The mobile economy Asia Pacific 2023. GSMA.
Gurzawska, A. (2020). Towards responsible and sustainable supply chains–innovation, multi-stakeholder approach and governance. Philosophy of Management, 19(3), 267-295.
Hao, X., & Demir, E. (2024). Artificial intelligence in supply chain decision-making: an environmental, social, and governance triggering and technological inhibiting protocol. Journal of Modelling in Management, 19(2), 605-629.
Ismail, A., Gan, Y. N., & Ahmad, N. (2020). Factors associated with patient satisfaction towards pharmacy services among out-patients attending public health clinics: Questionnaire development and its application. PLOS ONE, 15(11), e0241082.
Karaduman, Ö. (2025). Blockchain-enabled supply chain management: A review of applications, frameworks and limitations. Applied Sciences, 15(9), 5168.
Laws of Malaysia. (1952). Poisons Act 1952 (Act 366, Revised 1989). Government of Malaysia.
Laws of Malaysia. (1952). Poisons Act 1952 (Act 366, Revised 1989). Government of
Ma, J. Y., Shi, L., & Kang, T. W. (2022). The effect of digital transformation on the pharmaceutical sustainable supply chain performance: The mediating role of information sharing and traceability using structural equation modeling. Sustainability, 15(1), 649.
Ministry of Health Malaysia. (2025). Guideline on online healthcare services. Ministry of Health Malaysia.
National Pharmaceutical Regulatory Agency (NPRA). (2018). Guideline on Good Distribution Practice (3rd ed.). Ministry of Health Malaysia.
National Pharmaceutical Regulatory Agency. (2018). Guideline on Good Distribution Practice (3rd ed.). Ministry of Health Malaysia.
Oluwagbade, E., Vincent, A., Oluwole, O., & Animasahun, B. (2023). Lifecycle governance for explainable AI in pharmaceutical supply chains: a framework for continuous validation, bias auditing, and equitable healthcare delivery. Int J Eng Technol Res Manag, 7(11), 54.
Oluwole, O., Emmanuel, E., Ogbuagu, O. O., Alemede, V., & Adefolaju, I. (2024). Pharmaceutical supply chain optimization through predictive analytics and value-based healthcare economics frameworks.
Shashi, M. (2023). Sustainable digitalization in pharmaceutical supply chains using theory of constraints: A qualitative study. Sustainability, 15(11), 8752.
Shen, J., Zhang, Q., Ma, H., & Li, H. (2024). Management of drug supply-chain information based on AI and vendor-managed inventory. BMC Medical Informatics and Decision Making, 24(51).
Sim, C., Kuo, T., & Chen, Y. (2022). Improving end-to-end traceability and pharmaceutical supply chains through blockchain. Frontiers in Blockchain, 5, 1033702.
Walter, A., Roth, A., & Khalil, S. (2025). Application of artificial intelligence in demand planning for supply chains: A systematic review. The International Journal of Logistics Management, 36(3), 672–699.
World Health Organization. (2017a, March 29). WHO launches global effort to halve medication-related errors in five years. World Health Organization.
World Health Organization. (2017b, November 28). 1 in 10 medical products in developing countries is substandard or falsified. World Health Organization.
Yusuf, S. N. B. S., Joseph, C. A., & Karuppannan, M. A. (2025). Sustainable Governance of Pharmacy Supply Chains with AI Integration: A Stakeholder Theory Perspective. International Journal of Academic Research in Economics and Management Sciences, 14(3), 773–786.
Copyright: © 2025 The Author(s)
Published by HRMARS (www.hrmars.com)
This article is published under the Creative Commons Attribution (CC BY 4.0) license. Anyone may reproduce, distribute, translate and create derivative works of this article (for both commercial and non-commercial purposes), subject to full attribution to the original publication and authors. The full terms of this license may be seen at: http://creativecommons.org/licences/by/4.0/legalcode